Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03332641
NCT03332641
Completed
Not Applicable

A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Improvement of Blood Cholesterol

Hanyang University1 site in 1 country70 target enrollmentJune 7, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHyperlipidemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hyperlipidemia
Sponsor
Hanyang University
Enrollment
70
Locations
1
Primary Endpoint
Changes of Cholesterol
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This study was conducted to investigate the effects of daily supplementation of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on improvement of Blood Cholesterol.

Detailed Description

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Citron(Citrus Junos Siebold ex Tanaka) Peel Extract or a placebo group. Blood cholesterol profiles before and after the intervention.

Registry
clinicaltrials.gov
Start Date
June 7, 2017
End Date
September 28, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yongsoon Park

Professor

Hanyang University

Eligibility Criteria

Inclusion Criteria

  • •Age 19-75 years with Total cholesterol 200-239 mg/dL

Exclusion Criteria

  • •Lipid lowering agent within past 6 months
  • •Severe cardiovascular disease(Mvodardial infarction, stroke, etc)
  • •Renal disease(Heredity hyperlipidemia, Acute/Chronic renal failure, Nephrotic syndrome, ect)
  • •Cancer, Respiratory organ disease(Asthma, Chronic obstructive pulmonary disease)
  • •Diabetes mellitus
  • •Allergic or hypersensitive to any of the ingredients in the test products
  • •History of disease that could interfere with the test products or impede their absorption
  • •Under antipsychotic drugs therapy within past 2 months
  • •History of alcohol or substance abuse
  • •Participation in any other clinical trials within past 2 months

Outcomes

Primary Outcomes

Changes of Cholesterol

Time Frame: 12 weeks

Changes of Cholesterol were assessed before and after the intervention

Secondary Outcomes

  • Changes of Lipid profile(12 weeks)
  • Changes of Oxidized LDL(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride LevelHyperlipidemias
NCT03828188Chonbuk National University Hospital50
Completed
Not Applicable
The Effect of Citrus Extract on Oxidative StressElderly
NCT03580447Maastricht University Medical Center37
Completed
Not Applicable
Efficacy and Safety of Fermented Ginseng Powder on Liver FunctionFatty Liver, Nonalcoholic
NCT03260543Chonbuk National University Hospital90
Completed
Not Applicable
Compare Effects of EpiCor and Vitamin C to Vitamin C Alone on the Common Cold or Influenza in Healthy ChildrenSigns and Symptoms, Respiratory
NCT04093206Cargill221
Completed
Not Applicable
Efficacy and Safety of Zingiber Officinale Roscoe Extract on Body FatObesity
NCT03260751Chonbuk National University Hospital80